Thierry Hannedouche
Overview
Explore the profile of Thierry Hannedouche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
839
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ingwiller M, Delautre A, Tivollier J, Edet S, Florens N, Couchoud C, et al.
Kidney Med
. 2025 Jan;
7(2):100944.
PMID: 39885936
Rationale & Objective: Chronic kidney disease (CKD) in patients with diabetes does not always equate to diabetic kidney disease (DKD). This study aims to delineate and compare the clinical characteristics,...
2.
Ingwiller M, Bozman D, Florens N, Cerasuolo D, Vigneau C, Couchoud C, et al.
Sci Rep
. 2024 Nov;
14(1):27447.
PMID: 39523415
Fluid overload predicts morbidity and mortality in dialysis patients. Diuretics can reduce fluid overload, but their effects on morbi-mortality following inception remain ill-defined. To determine whether diuretics reduce mortality and...
3.
Dimitrov Y, Krummel T, Chantrel F, Heibel F, Kribs M, Hannedouche T
BMC Nephrol
. 2024 Nov;
25(1):391.
PMID: 39482652
Patients with chronic kidney disease (CKD) on dialysis have a higher mortality rate associated with SARS-CoV-2 infection. Although vaccines are now available, the protective response rates and determinants of humoral...
4.
Ingwiller M, Keller N, Krummel T, Prinz E, Steinmetz L, Hannedouche T, et al.
Clin Kidney J
. 2024 Oct;
17(8):sfae220.
PMID: 39421238
Background: Establishing the optimal timing for creating vascular access in patients with chronic kidney disease (CKD) is a critical and challenging aspect of patient management. The Kidney Disease: Improving Global...
5.
Perrin P, Muller C, Dimitrov Y, Chantrel F, Heitz M, Woerly A, et al.
Clin Kidney J
. 2024 Jul;
17(7):sfae169.
PMID: 39056068
No abstract available.
6.
Ku E, Inker L, Tighiouart H, McCulloch C, Adingwupu O, Greene T, et al.
Ann Intern Med
. 2024 Jul;
177(7):953-963.
PMID: 38950402
Background: In patients with advanced chronic kidney disease (CKD), the effects of initiating treatment with an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin-receptor blocker (ARB) on the risk for kidney failure...
7.
Granal M, Brokhes-Le Calvez S, Dimitrov Y, Chantrel F, Borni-Duval C, Muller C, et al.
Clin Kidney J
. 2024 Jun;
17(6):sfae095.
PMID: 38915433
Background: In recent years, a number of predictive models have appeared to predict the risk of medium-term mortality in hemodialysis patients, but only one, limited to patients aged over 70...
8.
Heerspink H, Eddington D, Chaudhari J, Estacio R, Imai E, Goicoechea M, et al.
Kidney Int
. 2024 Jun;
106(4):688-698.
PMID: 38901604
Pharmacologic interventions to slow chronic kidney disease progression, such as ACE-inhibitors, angiotensin receptor blockers, or sodium glucose co-transporter 2 inhibitors, often produce acute treatment effects on glomerular filtration rate (GFR)...
9.
Ku E, Tighiouart H, McCulloch C, Inker L, Adingwupu O, Greene T, et al.
J Am Soc Nephrol
. 2024 Jun;
35(10):1402-1411.
PMID: 38889197
No abstract available.
10.
Bozman D, Bazin D, Lavainne F, Hamroun A, Couchoud C, Hannedouche T
J Nephrol
. 2023 Sep;
36(7):2047-2056.
PMID: 37768547
Background: Diuretics can reduce fluid overload but their effects on conditions of dialysis start remain elusive. We aimed to determine whether loop diuretics exposure in the year before inception can...